Back
Juniper Networks 10K Form
Buy
51
JNPR
Juniper Networks
Last Price:
28.90
Seasonality Move:
3.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-27 | 10Q | JNPR/Juniper Networks Quarterly |
2023-07-28 | 10Q | JNPR/Juniper Networks Quarterly |
2023-04-28 | 10Q | JNPR/Juniper Networks Quarterly |
2023-02-10 | 10K | JNPR/Juniper Networks Annual |
2022-10-28 | 10Q | JNPR/Juniper Networks Quarterly |
2022-07-29 | 10Q | JNPR/Juniper Networks Quarterly |
Receive JNPR News And Ratings
See the #1 stock for the next 7 days that we like better than JNPR
JNPR Financial Statistics
Sales & Book Value
Annual Sales: | $5.3B |
---|---|
Cash Flow: | $288.4M |
Price / Cash Flow: | 11.3 |
Annual Sales: | $13.58 |
Price / Book: | 2.1 |
Profitability
EPS (TTM): | 1.12000 |
---|---|
Net Income (TTM): | $366.3M |
Gross Margin: | $2.96B |
Return on Equity: | 8.35% |
Return on Assets: | 3.95% |
Juniper Networks Earnings Forecast
Key Juniper Networks Financial Ratios
- The Gross Profit Margin over the past 25 years for JNPR is 55.80%.
- The Selling, General & Administrative Expenses for JNPR have been equal to 26.09% of Gross Profit Margin.
- The Research & Development expenses have been 19.54% of Revenue.
- The Interest Expense is 12.44% of Operating Income.
- The Net Earning history of JNPR is 8.88% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 12 years.
Juniper Networks Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Communication Equipment |
Sector: | Technology |
Current Symbol: | JNPR |
CUSIP: | 48203R |
Website: | juniper.net |
Debt
Debt-to-Equity Ratio: | 0.37 |
---|---|
Current Ratio: | 1.73 |
Quick Ratio: | 1.03 |
Price-to-Earnings
Trailing P/E Ratio: | 19.98 |
---|---|
Forward P/E Ratio: | 12.26 |
JNPR Technical Analysis vs Fundamental Analysis
Buy
51
Juniper Networks (JNPR)
is a Buy
Is Juniper Networks a Buy or a Sell?
-
Juniper Networks stock is rated a Buy
The current Juniper Networks [JNPR] share price is $28.57. The Score for JNPR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.